Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loren Waters

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Pharmacology & Translational Science|March 20, 2025
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic PotentialAzeza M Fdel, Loren Waters, Ira Sharma, et al.
Journal of Medicinal Chemistry|October 7, 2022
Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular ActivityRoss Collins, Hyunah Lee, D Heulyn Jones, et al.
Journal of Medicinal Chemistry|August 6, 2025
Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK InhibitorsAlex G Baldwin, David W Foley, D Heulyn Jones, et al.
Journal of Medicinal Chemistry|December 23, 2024
Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X SyndromeAlex G Baldwin, David W Foley, Ross Collins, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Pharmacology & Translational Science|March 20, 2025
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic PotentialAzeza M Fdel, Loren Waters, Ira Sharma, et al.
Journal of Medicinal Chemistry|October 7, 2022
Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular ActivityRoss Collins, Hyunah Lee, D Heulyn Jones, et al.
Journal of Medicinal Chemistry|August 6, 2025
Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK InhibitorsAlex G Baldwin, David W Foley, D Heulyn Jones, et al.
Journal of Medicinal Chemistry|December 23, 2024
Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X SyndromeAlex G Baldwin, David W Foley, Ross Collins, et al.
Pageof 1